Literature DB >> 15334631

Risk factors for peritoneal dissemination of colorectal cancer.

Shung-Haur Yang1, Jen-Kou Lin, Chiung-Ru Lai, Chien-Chih Chen, A Fen-Yau Li, Wen-Yih Liang, Jeng-Kae Jiang.   

Abstract

BACKGROUND AND OBJECTIVES: The aim of this study was to clarify the risk factors associated with positive peritoneal dissemination (PPD) of colorectal cancer (CRC).
METHODS: From June 2000 to September 2002, 143 CRC patients who underwent elective curative (79.0%) or non-curative (21.0%) open laparotomy were prospectively studied. Clinical evaluations including classical factors, colonoscopic evaluation, intraoperative evaluation, and pathological features were recorded. PPD was diagnosed when macro- (MAPD) or microscopic peritoneal dissemination (MIPD) was evident. Positive peritoneal cytology from initially existing ascites or washing lavage indicated MIPD. Various factors were analyzed with univariate (Chi-square test) and then multivariate analyses (logistic regression test) to search for the risk factors of PPD.
RESULTS: Overall, MIPD, MAPD, and PPD were found in 2.8%, 6.3%, and 9.1%, respectively. Univariate analysis identified age (< or =59 years), CA19-9 (> or = 34.6 U/ml), poor differentiation, circumferential involvement (> or = 3 quadrants), ascites volume (>80 ml), pN+, and pT4 as risk factors of PPD. PPD did not occur in patients with well-differentiated tumors, less circumferential involvement (< 2 quadrants), or no lymph node metastasis. After multivariate analysis, CA19-9 (Odds ratio (95% CI), 8.6 (1.7-43.1)), pT4 (9.0 (1.3-61.0)), and age (5.26 (1.1-25.0)) remained significant risk factors.
CONCLUSION: CA19-9 (> or = 34.6 U/ml), pT4, and age (< or =59 years) were significant risk factors of PPD. Copyright 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15334631     DOI: 10.1002/jso.20109

Source DB:  PubMed          Journal:  J Surg Oncol        ISSN: 0022-4790            Impact factor:   3.454


  20 in total

Review 1.  Peritoneal carcinomatosis of colorectal origin: incidence and current treatment strategies.

Authors:  Manuel J Koppe; Otto C Boerman; Wim J G Oyen; Robert P Bleichrodt
Journal:  Ann Surg       Date:  2006-02       Impact factor: 12.969

2.  Positive peritoneal washing cytology is a potential risk factor for the recurrence of curatively resected colorectal cancer.

Authors:  Yoichiro Homma; Takashi Hamano; Yasuhiro Akazawa; Yoshiro Otsuki; Shinichi Shimizu; Hiroshi Kobayashi; Shingo Kameoka; Yasuyuki Kobayashi
Journal:  Surg Today       Date:  2013-08-14       Impact factor: 2.549

Review 3.  Intra-operative peritoneal lavage for colorectal cancer.

Authors:  Guillaume Passot; Kayvan Mohkam; Eddy Cotte; Olivier Glehen
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

4.  Clinical Usefulness of Serum CYFRA 21-1 in Patients with Colorectal Cancer.

Authors:  Jai Hyuen Lee
Journal:  Nucl Med Mol Imaging       Date:  2013-08-06

5.  High-risk Stage II Colorectal Cancers Carry an Equivalent Risk of Peritoneal Recurrence to Stage III.

Authors:  Hiroaki Nozawa; Kazushige Kawai; Keisuke Hata; Toshiaki Tanaka; Takeshi Nishikawa; Kensuke Otani; Kazuhito Sasaki; Manabu Kaneko; Shigenobu Emoto; Koji Murono
Journal:  In Vivo       Date:  2018 Sep-Oct       Impact factor: 2.155

Review 6.  Prognostic and predictive response factors in colorectal cancer patients: between hope and reality.

Authors:  Chiara De Divitiis; Guglielmo Nasti; Massimo Montano; Rossella Fisichella; Rosario Vincenzo Iaffaioli; Massimiliano Berretta
Journal:  World J Gastroenterol       Date:  2014-11-07       Impact factor: 5.742

7.  Discovery of genes from feces correlated with colorectal cancer progression.

Authors:  Chia-Long Lee; Chi-Jung Huang; Shung-Haur Yang; Chun-Chao Chang; Chi-Cheng Huang; Chih-Cheng Chien; Ruey-Neng Yang
Journal:  Oncol Lett       Date:  2016-08-31       Impact factor: 2.967

8.  Evaluation of intraperitoneal lavage cytology before colorectal cancer resection.

Authors:  Shoichi Fujii; Hiroshi Shimada; Shigeru Yamagishi; Mitsuyoshi Ota; Chikara Kunisaki; Hideyuki Ike; Yasushi Ichikawa
Journal:  Int J Colorectal Dis       Date:  2009-05-28       Impact factor: 2.571

9.  The clinical significance of preoperative serum levels of carbohydrate antigen 19-9 in colorectal cancer.

Authors:  Hyeon Yu; Gyung-Mo Son; Yong-Geul Joh
Journal:  J Korean Surg Soc       Date:  2013-03-26

10.  Development and Validation of a Prognostic Nomogram for Colorectal Cancer Patients With Synchronous Peritoneal Metastasis.

Authors:  Zifeng Yang; Yong Li; Xiusen Qin; Zejian Lv; Huaiming Wang; Deqing Wu; Zixu Yuan; Hui Wang
Journal:  Front Oncol       Date:  2021-07-01       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.